- Display 45 Products per page
Published: December 29, 2015 | Price: $696.50 – $1,393.00
Point of Care (POC) Pregnancy and Fertility Testing Market The female reproductive system is complex both in structure and in function. From birth to senescence, the organs of the female reproductive system function in concert with each other, with the brain, and with other endocrine organs. This integrated functioning constitutes some of the most intricate and elegant processes of the human body. Because the functioning of the female reproductive system has an enormous impact on the life of the individual...Published: November 7, 2003 | Price: $746.00 – $1,492.00
Over the past three years, Kalorama Information's analysts have studied drug delivery markets from several angles. In 2001 and 2002, we published a 5-volume series on drug delivery technology, each volume devoted to a route of administration: Volume I: Oral Drug Delivery Volume II: Injectable and Implantable Drug Delivery Volume III: Pulmonary Drug Delivery Volume IV: Transdermal and Transmucousal Drug Delivery Volume V: Advanced Drug Delivery This series segmented the market by technology and included an innovative analysis that estimated...Published: May 1, 2013 | Price: $750.00 – $1,995.00
The Global Market for Medical Devices, 4th. Edition- Medical device makers faced challenging year in 2012. New taxes in the United States, financial tightening and regulatory threats in Europe. They consolidated, launched new devices and invested in R&D in response. In this report, The Global Market for Medical Devices, 4th. Edition, Kalorama Information analyzes the current device market in the United States, Europe, Asia and globally, profiles the key players and discusses trends important for market watchers to know. The...Published: March 11, 2014 | Price: $750.00 – $1,500.00
Retail Clinics Market Overview and 2014 Survey Results Retail clinics are medical settings located in a retail store. They are not free standing and do not offer all medical services. Yet they provide an option for busy Americans seeking a convenient option for basic healthcare needs such as vaccinations or cold remedies. Kalorama Information has published several studies on retail clinics since 2007. Over the past few years, we have analyzed the economic performance of stores and opportunities for suppliers....Published: August 26, 2014 | Price: $750.00 – $1,500.00
Big Data and Healthcare This Kalorama Information report, Big Data in Healthcare, outlines the key deals, mergers, consortia, and competitive events that have been formed in an attempt to meet the challenge of using healthcare data to enhance practice and boost revenues. Big data consists of the giant data pulls that emerge in every day use from manufacturers, healthcare organizations, governments, scientists and others. Those working with big data are seeking insights into the management of these large datasets. If...Published: April 7, 2020 | Price: $750.00 – $1,000.00
For years, Kalorama Information has covered the fields of molecular diagnostics, immunoassays, vaccines and telehealth. These all find themselves both sought-after and challenged during the current COVID-19 crisis. This report provides trending developments, company announcements and analysis from the Kalorama analysis team on the fast-breaking events in the COVID-19 epidemic. Particular sections address the most important market changes: Molecular Diagnostics: It's important to note that the entire molecular testing concept originated in the midst of a crisis, at that time...Published: November 9, 2017 | Price: $760.00 – $1,600.00
This Kalorama Information report covers the market for virtual reality and augmented reality systems related to medical education and training. The market for virtual reality (VR) and augmented reality (AR) products and services in medical education and healthcare training is predominately based in surgical simulators. Virtual reality and augmented reality technology has developed into a comprehensive tool in the surgical workflow – assisting training, rehearsal, and surgical performance in operating room (OR). The growing volume and variety of minimally invasive...Published: March 1, 2004 | Price: $795.00 – $1,590.00
The hard-fought battle over Medicare's prescription drug benefit is over, but the long-term effects of the new law are still unclear. Exactly who will benefit and by how much? Is it a victory for big pharma? Initial reactions are not always correct, and this examination into the true implications for pharmaceutical markets looks at all the facts. This market briefing from Kalorama describes and assesses the provisions of the "Medicare Prescription Drug, Improvement and Modernization Act of 2003" and predicts...Published: August 1, 2005 | Price: $795.00 – $1,990.00
Neurological disease that impacts the sensory pathway can produce severe chronic pain, also known as neuropathic pain. This usually is unrelated to any peripheral tissue injury. This occurs with disorders of the central nervous system (CNS), such as stroke and multiple sclerosis, or with conditions associated with peripheral nerve damage, such as mechanical injury, diabetic neuropathy or herpes zoster infection. On form of neuropathic pain that is just now gaining recognistino is complex regional pain syndrome (CRPS), also known as...Published: September 1, 2005 | Price: $795.00 – $1,590.00
One of the keys to understanding many complex biological interactions, is the role played by specific carbohydrates. This is glycobiology. While many glycobiology-related products commercialized to date are detection and analysis kits for analyzing glycoproteins and the extent of glycosylation, a newer body of research is harnessing glycobiology to develop glycol-based drugs, or glycotherapeutics. The glycosylated therapeutics business is among the faster growing segments in the drug industry, but the development of novel glycosylated therapies is only in the early...Published: January 26, 2016 | Price: $796.00 – $1,592.00
Point of Care (POC) Cholesterol Testing Market Point of Care (POC) Cholesterol Testing Market presents the revenue picture for cholesterol testing performed at or near the site where the patient is located. The following data regarding the POC cholesterol market are provided: world POC cholesterol testing revenue estimates, 2012-2020; POC cholesterol self-testing revenue estimates, 2015 and 2020; POC cholesterol professional testing revenue estimates, 2015 and 2020; world POC cholesterol testing revenue estimates and market share of leading manufacturers, 2014; and...Published: April 13, 2016 | Price: $796.00 – $6,720.00
EMR 2016: The Market for Electronic Medical Records EMR 2016 examines the marketplace and trends affecting electronic medical record (EMR) software and related services. This 499-page contains statistics influencing the business, demographics, life expectancy, and competitor strategies. This total market analysis includes EMR revenue analysis, 2013-2020; revenue share (%) of EMR companies, 2015; hospital EMR revenue estimates: 2013-2020; physician/Web-based EMR revenue estimates: 2013-2020; and sales and market share of EMR manufacturers, 2015. This market review also features EMR revenue analysis...Published: April 26, 2016 | Price: $796.00 – $6,720.00
qPCR and dPCR Markets (Instruments, Reagents, Software/Services) This Kalorama Information study, qPCR and dPCR, analyzes the market for these workhorse technnologies in detail, providing detailed market sizing and forecasts for both the research and clinical PCR market are provided to 2020. Trends are discusssed, competitors profiled and useful business planning data provided. The report estimates markets and forecasts markets for reagents, instruments, software/services used in PCR. Regions covered include: US, Europe, Asia and Rest of World.Published: July 27, 2016 | Price: $796.00 – $1,592.00
Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2025 Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2025 analyzes the leading concerns in the pharmaceutical industry, including the late-term pipeline of major competitors. This report provides long-term company sales forecasts based recent market conditions. For each company covered, the report includes late stage product pipeline; late stage product pipeline by therapeutic area, comparing 2009, 2011, 2013 and 2015; total company revenue and total R&D spending, 2011-2015;...Published: January 10, 2017 | Price: $796.00 – $1,592.00
Mergers and Acquisitions in the IVD Market Mergers and Acquisitions (M&A) activity in the in vitro diagnostics (IVD) market was brisk in 2016. Kalorama's report records 250 acquisitions in the industry from 2013-2016. Becton Dickinson (BD), Danaher, Roche, and Thermo Fisher Scientific were among the companies active in M&A during this period.Published: April 17, 2017 | Price: $796.00 – $1,592.00
Out-of-Pocket Healthcare Expenditures in the United States Out-of-Pocket Healthcare Expenditures in the United States examines the average person’s out-of-pocket medical costs, including: Distribution of Out-of-Pocket Spending for the Average Person, 2016, 2021 Consumer Out-of-Pocket Expenditures per Worker, 2011–2021 Consumer Out-of-Pocket Expenditures by Type, 2011–2021 Proportion of Consumer Out-of-Pocket Spending by Type of Healthcare Expenditure, 2011, 2016, 2021 Average Share Paid Out-of-Pocket by U.S. Residents with Healthcare Spending by Percentile of Total Health Spending and Type of Service, 2016 Average Share...Published: February 19, 2017 | Price: $796.00 – $1,592.00
World Sleep Apnea Device Markets is Kalorama Information's authoritative study on this high-growth market. As part of its coverage, the report provides the following data: Worldwide Respiratory Sleep Apnea APAP Market, 2014-2021 ($millions) Sleep Apnea Bi-Level Market Worldwide Respiratory Sleep Apnea Bi-Level Market, 2014-2021 ($millions Sleep Apnea Facial Interface and Diagnostic Device Market Worldwide Respiratory Sleep Apnea Facial Interface and Diagnostic Device Market, 2014-2021 ($millions) Prevalence of Sleep Apnea, 2015 Sleep Apnea Prevalence by Region and Country, 2015 Worldwide...Published: June 22, 2018 | Price: $800.00 – $1,600.00
Are Consumers Visiting Retail Clinics? What For? How Satisfied are Retail Clinic Customers? These questions and many others are answered in this report from Kalorama Information. Kalorama has covered the market for clinics located within a retail health setting since 2007, and has recently concluded a web-based survey of 2000 U.S. adults, where hundreds of retail clinic users were interviewed. This report provides the results of this survey. Questions Asked Include: Have You Ever Visited A Retail Clinic? Gender Of...Published: July 1, 2004 | Price: $895.00 – $1,790.00
Alternative routes of administration for insulin has been one of the leading drivers of drug delivery industry. Although transdermal and transmucosal systems have shown promise and true oral delivery remains a goal, pulmonary delivery has emerged as the leading area of development. Several major players in the pharmaceutical industry have given their backing to inhaled insulin projects, and product launches are imminent. However, the exact make-up of the market, patient acceptance, and regulatory progress are still not completely clear. This...Published: August 1, 2004 | Price: $895.00 – $1,790.00
After years of neglect, concerns over pain, how it is assessed and managed on a patient-by-patient basis have captured the attention of health care professionals and the public. There are a variety of issues that have acted to draw this attention, including the high prevalence of pain, continuing evidence that pain is undertreated and a growing awareness of the negative consequences of poor pain management. Infusion pumps were first introduced in the 1960s. These devices ushered in a whole new...Published: September 1, 2004 | Price: $895.00 – $1,790.00
Nanotechnology is no longer a bench-top curiosity. It is becoming a real commercial force for a variety of applications. This market briefing discusses the state of play in the race to commercialize products and forecasts likely market scenarios. The briefing forecasts the market in generally promising areas such as cancer therapeutics, specialized drug delivery, diagnostics, and topical therapies, reviewing what companies are doing in those markets.Published: October 1, 2004 | Price: $895.00 – $1,790.00
There is a pressing need for new anticoagulant therapeutics in human medicine. To meet this need, developers are reformulating traditional cornerstone therapeutics such as heparin and looking to new classes such as DTIs to prevent stroke and myocardial infarction and treat deep vein thrombosis and a host of other emerging indications. This briefing analyzes the potential world medical markets for new anticoagulant therapies. Revenue projections through 2010 are made for four geographic regions and for two potentially blockbuster products. This...Published: October 1, 2005 | Price: $895.00 – $5,990.00
Information technology (IT) has the potential to improve the quality, safety and efficiency of clinical care. IT is not new to the hospital setting. Computers and software have been used for many years to improve the paper-based administrative functions of hospital support staff, such as scheduling and billing. But the use of IT in the clinical setting to optimize, streamline and simplify patient records, testing, imaging and operating room procedures has lagged behind its medical administrative applications. The evolution of...Published: February 1, 2008 | Price: $895.00 – $6,990.00
Congestive heart failure is an increasingly important cause of cardiovascular morbidity and mortality. It is the number one cause of hospitalization among individuals aged 65 and over. The United States Medicare system pays out more for the care of congestive heart failure than it does for all forms of cancer combined. While this is a challenge for the US healthcare system, it indicates a strong market opportunity for pharmaceutical companies involved in CHF treatment. Kalorama Information's Congestive Heart Failure, Major...Published: June 1, 2003 | Price: $995.00 – $2,992.00
According to the Pharmaceutical Research and Manufacturers of America (PhRMA) more than 1,000 drugs are in various stages of development. Similarly, breakthroughs in the medical device arena such as coronary stents, implantable defibrillators, and minimally invasive bypass surgery and advances in DNA-based tests and other advanced diagnostics are detecting cancer and other diseases earlier when they are more treatable are moving from dream to reality. It is obvious that even if all of these drugs and devices make it to...Published: August 1, 2004 | Price: $995.00 – $1,910.00
Blood banking has been the most dynamic testing segment to adopt molecular diagnostics approaches since their introduction. Screening for HIV, HCV and HBV in donated blood, plasma and organs has largely been done by immunoassay procedures. In conjunction with background screening, this has become a very effective approach toward guaranteeing the safety of the blood/organ supply. However, there is a lag time between infection with these viruses and the production of antibodies against them. In some cases, such as HBV,...Published: October 1, 2004 | Price: $995.00 – $1,990.00
The field of pharmacogenetics promises to open up new opportunities for the diagnostic industry at the same time it opens the door to more effective therapeutics. Pharmacogenetics is based on the principle that the effects of a given medication when administered to a patient are determined, at least in part, by his or her genetic constitution. Differences in drug metabolism may lead to varying adverse events or more pronounced adverse events in different individuals, and differing metabolism may also lead...Published: October 1, 2004 | Price: $995.00 – $1,990.00
Currently, the largest market application segment for molecular diagnostics is that for infectious disease testing. The segment is expected to grow at an annual rate between 7% and 8% over the next few years will present some excellent market opportunites for molecular diagnostic competitors. This summary report, extracted from Kalorama Information’s U.S. Market for Molecular Diagnostics, (2nd Edition, May 2004), focuses on the technologies and application of molecular diagnostics in the field of infectious disease testing. The major market effects...Published: October 1, 2004 | Price: $995.00 – $1,990.00
Gene and chromosome testing for inherited diseases currently represents the third largest molecular diagnostics testing segment in the U.S. Assays in this market address applications in genetic carrier and predisposition testing. Currently, most testing is for prenatal screening and for assessing clinically suspect newborns for various chromosomal abnormalities (e.g., Down’s syndrome, fragile X syndrome). Some testing is used for genetic counseling for couples planning to have children. Such diagnostics test for the presence of carrier states of diseases such as...Published: January 15, 2005 | Price: $995.00 – $1,990.00
Despite the traditional notion that nothing therapeutic can be accomplished for the 1.5 million Americans with autism and the 2 million more throughout the world, there are pharmacologic approaches to the disease that are providing some help for patients and garnering revenues for drug companies. This Market Briefing reviews the market for drugs used in the treatment of autism and related disorers, including Antidepressants, Anti-Anxiety drugs, Anti-psychotics, Anti-convulsants, and CNS stimulants for ADHD-related symptoms, forecasting revenues through 2009 gloabally and...Published: February 1, 2005 | Price: $995.00 – $1,990.00
Neurological catheters, also known as microcatheters, are small devices that can navigate the intricate intracranial vasculature of the brain. These catheters--some on the market, others in development--are used for a variety of applications, including aneurysm occlusion, chronic pain relief, targeted drug delivery, tumor embolization, treating vascular malformations, brachytherapy, and vasospasm therapy. They also promise to be extremely useful in the delivery of therapeutic genes or stem cells to patients who may have a variety of neurological diseases. This report analyzes...Published: February 1, 2005 | Price: $995.00 – $1,990.00
Computer-based technologies offer significant potential for improving the clinical outcomes of patients. Computer software and hardware, as well as the systems they control, have begun to impact the manner in which surgeons design, plan, simulate and perform surgery. In the last few years, automated and computer-assisted techniques have found increased use in surgical procedures as tools for performing difficult neurosurgery, cranio-facial surgery and some orthopedic procedures. These techniques give the surgeon more advanced capabilities than were available previously, such as...Published: April 1, 2005 | Price: $995.00 – $1,990.00
Schizophrenia is a life long affliction. There is no permanent cure for this illness. However, numerous drugs have made the effective management of the disease a reality. This briefing examines both corrent and emerging therapeutic approaches for the management of schizophrenia. It provides an analysis of the current and future markets for these agents, including forecasts to 2009 segmented by geographic region and by type of drug and likely market scenarios for new agents not yet available. The briefing discusses...Published: June 1, 2005 | Price: $995.00 – $1,990.00
In addition to being one of the most important tissues in the body, blood has emerged as a key vector in the transmission of the world's deadliest infectious diseases. With the rising demand for transfusions in a variety of conditions such as anemias, trauma, and high-blood-loss surgeries, supplies have been stretched and the dangers of disease transmission have added significant cost pressures to maintaining a safe supply. One possible solution to ease the crunch, particularly in acute amergency care settings...Published: June 1, 2005 | Price: $995.00 – $1,990.00
Interest in and use of the technology has exploded in recent years, thanks to advances in cell biology, biochemical agents, and computer analysis. Research groups around the world are joining the effort to use magnetic, nuclear, and optical imaging techniques to study the molecular interactions that underlie biological processes. This market briefing presents an overview of the market for molecular imaging agents and systems. The briefing provides an introduction to molecular imaging modalities and applications, and focuses on imaging agents...Published: June 1, 2005 | Price: $995.00 – $1,990.00
With the promise of improved outcomes and shorter recovery times and costs, endoscopic surgery has evolved into an accepted surgical discipline in most therapeutic areas. However, spine surgeons in particular have been slow to embrace this new technology over the past decade or so. Challenges specific to the spinal column have made the adoption of minimally invasive surgery difficult, but endoscope manufacturers have begun to take advantage of technological advances in endoscopic visualization and other arrears to optimize the minimal-access...Published: September 1, 2005 | Price: $995.00 – $7,000.00
In the industrial world, over 240 million people lack one or more teeth. It is estimated that 40% of the western population is missing one tooth or more. In the United States, approximately 10% is the population is totally edentulous, and every year about two million Americans loose a tooth due to sporting accidents. Although the success of modern dentistry in the United States has vastly decreased the edentulous rate in each succeeding generation, it is estimated there are about...Published: January 1, 2006 | Price: $995.00 – $5,990.00
With the mapping of the human genome and the concomitant explosion of proteomics, a steady stream of biopharmaceuticals have been launched—recombinant therapeutic proteins, monoclonal antibody-based products used for therapeutic or in vivo diagnostic purposes, and nucleic acid-based products. As the rate of regulatory approval for biopharmaceuticals increases, the number of products reaching the market will impose unprecedented demands on the industry’s biomanufacturing capacity. Whether or not this will create a biomanufacturing bottleneck is a hotly debated issue in the industry....Published: June 1, 2006 | Price: $995.00 – $7,800.00
The protein therapeutics sector is a story of triumphant science, representing both life-saving treatments for millions and a multi-billion dollar industry. This report details both the scientific and business aspects of the protein therapeutics marketplace, including market size and growth, competitive market share, geographical segmentation, top products, and forecasts to 2010 for each of the following individual product areas: Monoclonal Antibodies Erythropoietins Insulin Interferons Growth Factors Interleukins Blood Clotting Factors Tissue Plasminogen Activator Human Growth Hormones Reproductive Hormones Recombinant BMP-2...Published: June 1, 2006 | Price: $995.00 – $5,990.00
This report focuses on the specific needs and market applications of the critical care pharmaceuticals market, the options presented by the market, the factors associated with strategic market development, and prospects for the future. The major indications for critical care are discussed as well as the range of pharmaceutical products used in the critical care environment. The strategic market characteristics of the critical care pharmaceuticals market are also discussed. The trends —- cost-containment programs, restricted formulary acceptance, clinical pharmacy, and...Published: June 1, 2006 | Price: $995.00 – $7,000.00
Despite troublesome safety problems with past entrants into this market, the veritable epidemic of overweight and obesity continues to make this sector an extremely attractive target for pharmaceutical developers. This new title provides a considered view of the market for medical interventions in the battle against obesity, including U.S. and worldwide market size and growth forecasts, competitive market share and extensive pharmaceutical pipeline information. The report discusses both prescription and OTC drug markets and surgical interventions. Market size and growth...Published: July 1, 2006 | Price: $995.00 – $7,000.00
This report provides and in-depth analysis of the market for prescription drugs used in the treatment of gastrointestinal (GI) disorders, such as nausea and vomiting, heartburn, gastro-esophageal reflux disease (GERD), ulcer, cancers of the GI tract (colorectal, esophageal, and gastric), Crohn’s disease, ulcerative colitis, irritable bowel syndrome (IBS), diverticular disease, constipation, celiac disease, short bowel syndrome, diarrhea, intestinal obstruction, and digestive enzyme disorders. For each major segment, the analysis provides an overview of the diseases including epidemiology, a detailed description...Published: October 1, 2006 | Price: $995.00 – $7,000.00
The orthopedic drug market is a highly competitive market and, in some areas, the competitive environment is being shaped by increasing levels of generic competition. Several large pharmaceutical companies compete in the orthopedic drug market, including Abbott, Eli Lilly, GlaxoSmithKline, Merck, Novartis, and Pfizer among others, and several other suppliers, such as Serono, NovoNordisk, Amgen, and Genentech are developing or offering products in more niche market areas. For the purposes of this study, the world market for orthopedic drugs has...Published: November 1, 2006 | Price: $995.00 – $5,990.00
Protein biomarkers have become the hot application area for mass spectrometry (MS) and other proteomics-related technologies in the last few years. In the short term, this move towards biomarkers and clinical proteomics research has happened mainly in the drug discovery and development process. However, they also have broad abilities to generate richer information about a disease state, drug response, and/ or the relation between the two; which can be used for diagnostic, prognostic, or various other purposes in the pharmaceutical,...Published: January 1, 2007 | Price: $995.00 – $3,990.00
Personalized medicine, the use of therapies that are targeted to the individual patient, is a reality today, thanks to a growing emphasis on biomarker research. Biomarkers promise a smoother integration of diagnostics and therapeutics, and most importantly a reduction in time and cost for Phase I and II clinical trials. Anyone looking to take advantage of the opportunities the market for biomarker research offers will find Kalorama’s Biomarkers: A Market Briefing an essential study of this emerging market. Not only...